The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-benzyl-3-[(2R,3S)-3-hydroxy-2-methyl-4-methylenenonanoyl]oxazolidin-2-one ID: ALA3764020
PubChem CID: 49847056
Max Phase: Preclinical
Molecular Formula: C21H29NO4
Molecular Weight: 359.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=C(CCCCC)[C@@H](O)[C@@H](C)C(=O)N1C(=O)OC[C@@H]1Cc1ccccc1
Standard InChI: InChI=1S/C21H29NO4/c1-4-5-7-10-15(2)19(23)16(3)20(24)22-18(14-26-21(22)25)13-17-11-8-6-9-12-17/h6,8-9,11-12,16,18-19,23H,2,4-5,7,10,13-14H2,1,3H3/t16-,18+,19-/m1/s1
Standard InChI Key: JSIYFMCFASVUJH-NZSAHSFTSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
6.2544 -0.2640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5052 1.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0378 0.7246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2500 -1.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9940 2.1315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5923 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9154 1.7169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4920 1.2410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3675 2.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0558 1.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1545 2.8928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2529 0.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6066 3.4109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6037 2.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1803 2.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7282 3.2711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1515 2.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0506 3.5899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8873 -3.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8792 -5.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5761 -6.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2812 -5.2469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2892 -3.7469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2551 0.7791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
2 6 2 0
7 8 1 0
4 7 1 6
9 10 1 0
10 11 1 0
11 12 1 0
9 13 2 0
10 14 1 6
11 15 1 1
3 9 1 0
12 17 1 0
16 17 1 0
16 18 1 0
18 19 1 0
19 20 1 0
8 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 8 1 0
12 26 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.47Molecular Weight (Monoisotopic): 359.2097AlogP: 3.71#Rotatable Bonds: 9Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.48CX LogD: 4.48Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: 0.60
References 1. Singh S, Gajulapati V, Gajulapati K, Goo JI, Park YH, Jung HY, Lee SY, Choi JH, Kim YK, Lee K, Heo TH, Choi Y.. (2016) Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers., 26 (4): [PMID:26810262 ] [10.1016/j.bmcl.2016.01.016 ]